Expert Opinion
Opinions and insights from thought leaders and clinicians on the front lines of care.
Commentary
Opinions and ideas from experts in oncology
Key GI and Lung Studies From The European Multidisciplinary Cancer Congress, Stockholm
2011 Oct 11, Jean-Yves Douillard, MD
EXPERT
Jean-Yves Douillard, MD, PhD
Interviews
Discussions with top medical experts
Dr. Andre Goy: Update on the Use of R-CHOP in Diffuse Large B-Cell Lymphoma
OncologySTAT Editorial Team. 2012 Jan 26, Interview by L Scott Zoeller
EXPERT
Andre Goy, MD
My Approach
Experts share their viewpoints on the management of difficult or controversial clinical scenarios
Dr. Roger Stupp: My Approach to Glioblastoma
OncologySTAT Editorial Team. 2011 Aug 9, Interview by L Scott Zoeller
EXPERT
Roger Stupp, MD
When The Smoke Clears
Experts discuss the true clinical implications of watershed developments in oncology research
Dr. Howard Scher on Circulating Tumor Cells
2011 Oct 6, Howard Scher, MD
EXPERT
Howard I. Scher, MD
Cancer Policy Forum
Behind-the-headlines perspectives from COA on health care reform and cancer-related drug legislation
Solution in Sight for the Cancer Drug Shortages?
2011 Dec 14, Patrick Cobb, MD; Ted Okon
EXPERT
Patrick W. Cobb, MD, FACP
EXPERT
Ted Okon
Ask the Expert
Leading experts answer clinical questions submitted by OncologySTAT users
Efficacy for Post-Transplant Rituximab in Lymphoma
2012 Jan 30, Andre Goy, MD
EXPERT
Andre Goy, MD
The Lancet Oncology: Comment
Expert commentaries that accompany original articles published in The Lancet Oncology
Hypofractionated Radiotherapy for Prostate Cancer
Lancet Oncol. 2012 Jan 1;13(1):5-6, BS Teh, et al
How Might HPV Testing Be Integrated Into Cervical Screening?
Lancet Oncol. 2012 Jan 1;13(1):8-10, HA Katki, et al
Cancer Policy Forum
Behind-the headlines perspectives on health care reform, cancer-related drug legislation, and other topics likely to have a major impact on oncology practice.
